Search - tctmd.com

Displaying 21 - 40 of 210

Sort: Relevancy | Date

Presentation TCT 2024

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

Presenter: Donna Lin

October 27, 2024

News Conference News TCT 2023

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

Todd Neale

October 31, 2023

Presentation TCT 2023

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

Presenter: Hyunki LEE

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

Presenter: Karlis Trusinskis

October 25, 2023

Presentation TCT 2023

How to Make Wire Escalation More Efficient (Antegrade and Retrograde Cases)

Presenter: Rhian Davies

October 24, 2023

Presentation TCT 2023

Long Term Maintenance Antiplatelet Therapy After PCI

Presenter: Hyo-Soo Kim

October 24, 2023

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

Presentation TCT 2023

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Presenter: Sripal Bangalore

October 24, 2023

Presentation TCT 2023

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Presenter: Harold Dauerman

October 24, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

Presenter: Ajar Kochar

September 19, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

Presenter: Gregory Serrao

September 19, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

Presentation TCT 2022

Short DAPT or De-Escalation After ACS

Presenter: Claudio Laudani

September 18, 2022

Presentation TCT 2022

TCT 816: Acute recoil following transcatheter aortic valve replacement with a self-expanding prosthesis in bicuspid aortic valve.

Presenter: Artemio Garcia-Escobar

September 17, 2022

Presentation TCT 2022

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

Presenter: Donggyu Moon

September 17, 2022

Presentation TCT 2022

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

Presenter: Niels van der Sangen

September 17, 2022

Presentation TCT 2022

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

Presenter: Jeehoon Kang

September 17, 2022

Advertisement

TCT 234: Sex Differences in the Safety and Efficacy of Short-term DAPT Versus DAPT De-escalation After Percutaneous Coronary Intervention

RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months

TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction.

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

How to Make Wire Escalation More Efficient (Antegrade and Retrograde Cases)

Long Term Maintenance Antiplatelet Therapy After PCI

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

De-Escalation of Antithrombotic Therapy: Why, in Whom, and How?

Antiplatelet Agents for Patients Undergoing PCI: Options and Pharmacologic Considerations

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Update From the AHA Expert Consensus Document: When/How to De-escalate MCS

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Update From the AHA Expert Consensus Document: When/How to Escalate MCS

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Short DAPT or De-Escalation After ACS

TCT 816: Acute recoil following transcatheter aortic valve replacement with a self-expanding prosthesis in bicuspid aortic valve.

TCT 18: De-Escalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients with High Ischemic Risk: Post hoc Analysis of TALOS-AMI Trial

TCT 17: Single Antiplatelet Therapy Directly After Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: The OPTICA Pilot Study

TCT 15: Dual antiplatelet therapy-based de-escalation in acute coronary syndrome: An individual patient data meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content